×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALGS – aligos therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALGS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
08:34 am
algs
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/5
08:00 am
algs
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
High
Report
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
2/26
08:00 am
algs
Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
Medium
Report
Aligos Therapeutics to Announce 4th Quarter 2025 Financial Results on March 5, 2026
2/23
08:00 am
algs
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Low
Report
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
1/30
08:00 am
algs
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/21
10:32 am
algs
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates [Yahoo! Finance]
1/21
08:00 am
algs
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
Low
Report
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
1/13
08:00 am
algs
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
Medium
Report
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
Date
Time
Symbol
Company Name
Action
%Chg
3/5/2026
08:00 am
ALGS
aligos therapeutics, inc. - common stock
BEAT
Report
-4.9%
aligos therapeutics, inc. - common stock
11/6/2025
08:30 am
ALGS
aligos therapeutics, inc. - common stock
MISS
Report
1.3%
aligos therapeutics, inc. - common stock
8/6/2025
04:05 pm
ALGS
aligos therapeutics, inc. - common stock
BEAT
Report
1.1%
aligos therapeutics, inc. - common stock
5/6/2025
08:00 am
ALGS
aligos therapeutics, inc. - common stock
BEAT
Report
-16.5%
aligos therapeutics, inc. - common stock
Date
Time
Symbol
Headline
Impact
3/5
08:08 am
algs
Form 10-K Aligos Therapeutics, For: Dec 31
Medium
Report
Form 10-K Aligos Therapeutics, For: Dec 31
3/5
08:02 am
algs
Form 8-K Aligos Therapeutics, For: Mar 05
Medium
Report
Form 8-K Aligos Therapeutics, For: Mar 05
2/19
05:54 pm
algs
Form 3 Aligos Therapeutics, For: Jan 29 Filed by: Aneja Nikhil
Medium
Report
Form 3 Aligos Therapeutics, For: Jan 29 Filed by: Aneja Nikhil
2/17
03:22 pm
algs
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Woodline Partners LP
Low
Report
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Woodline Partners LP
2/11
04:32 pm
algs
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Sio Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Sio Capital Management, LLC
2/4
04:07 pm
algs
Form 8-K Aligos Therapeutics, For: Jan 29
Medium
Report
Form 8-K Aligos Therapeutics, For: Jan 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: